Company / Operating Income per Share
Neogen Operating Income per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$4.91
FY2024
5-year range
-$4.91 / $0.55
FY2020-FY2024
Trend
-1001.6%
vs FY2023
Sector context
#144 of 149
Health Care
What the data says
Operating Income per Share changed -1002% YoY in FY2024, a notable deviation from the 8-year average annual change of -132%.
Based on SEC 10-K filings.
-4.91 in FY2024.
Declined from $0.35 to $-4.91 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 149This company -$4.91 Sector average $4.30
▼
-214.1% below sector average
Key checks
Key Insights
- In FY2024, operating income per share decreased 1001.6% year-over-year.
- Ranks #144 out of 149 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -$4.91 | -1001.6% |
| FY2023 | $0.54 | +55.9% |
| FY2022 | $0.35 | -36.9% |
| FY2021 | $0.55 | -61.0% |
| FY2020 | $1.42 | +8.8% |
| FY2019 | $1.31 | -2.4% |
| FY2018 | $1.34 | -28.4% |
| FY2017 | $1.87 | +6.8% |
| FY2016 | $1.75 | +14.0% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026